MARKET
STUDIES
BUSINESS
SERVICE
PORTFOLIO
MANAGEMENT
STRATEGY
Helmut Kaiser
Consultancy
Unternehmensberatung
RESEARCH
Investment &
Investor Service,
Change-Management
Technology-Market,
Stockmarkets Worldwide
21. Century Trends
State of Science,
Trends and Waves,
Technologies
Multi-client,
Exclusive,
Political
Business Development,
JV, M+A,
Audits
Summary Regarding China's Growth Markets.
can be ordered now!
Your China Business
Your address in Beijing from 150 $ per month

Your company/repr. from 200 $ per month

We establish your company from 3000 $

Furrther services:
Market research
Consultancy
Legal service
Tax service
Recruitment service
Business service
for more, please click
China Stock-
market Service
We build your portfolio from 50,000 US$

We open your bank account with your address in Beijing

Further services:
Research
Risk studies
Portfolio management
for more, please click
GREEN JOBS
Specialists, Executives, Management
Home
STUDY and BOOK new 2014
Alzheimer 2040
Alzheimer and Alzheimer Business



























Part A as hardcover Book 49 Euro + 5 Euro Postage
Part A as e-Book150 Euro

Part A and B as total study      4900 Euro




Worldwide Market for Alzheimer’s Disease (AD) Business 2013-2040
Diagnostic, Prevention, Therapy, Research, Competition


PART A: Alzheimer’s Disease – Background, Diagnosis, Prevention, Therapy, Research

I.Initial Situation
II.Background information
a.Definition of Dementia
b.Definition of Alzheimer’s Disease (AD)
c.ICD-10
d.Epidemiology
e.Stages of AD
i.Pre dementia
ii.Early
iii.       Moderate
iv.Advance
f.Pathophysiology/Disease mechanism
i.Causes
ii.Neuropathology
iii.Genetics
III.Diagnosis
a.Criteria
b.Techniques
i.Imaging
ii.non imaging
iii.biomarkers
iv.others                                   
IV.Prevention
a.Food
b.Supplements
c.Herbal
d.Brain training
e.others
V.Therapy and Patient management
a.Overview
b.Care facilities
c.Nursing homes
d.Specialized institutions
e.Others
VI.Prognosis
VII.Burden of disease
a.Cost
b.Acceptance
c.State of research


B Markets for Alzheimer’s Disease (AD) Worldwide 2012-2040 – Regions, Countries, Prevention, Diagnosis, Therapy

I.Market for Dementia Worldwide
a.Market for Dementia worldwide by regions
b.Market for Dementia worldwide by leading countries
c.Market for Dementia patient care worldwide

II.Market for Alzheimer Worldwide
a.Market for AD worldwide by regions
b.Market for AD worldwide by leading countries
c.Market for AD diagnostics worldwide
d.Market for AD therapy worldwide
e.Market for AD prevention worldwide
f.Market for AD Patient management / care
g.Value Chain
h.Current Market Situation
i.Competition
j.Trends and Developments
k.Research
l.Company Overview

III.Market for Diagnostics
a.Overview of AD Diagnostics
i.Tests
1.Cognitive
2.Neurophysiological
ii.Neuroimaging
1.SPECT
2.PET
3.MRI
iii.Cerebrospinal fluid
iv.Blood tests
1.Biomarkers
2.Others
v.Others
b.Worldwide Markets for AD diagnostics by technologies/segments
c.Worldwide Markets for AD diagnostics by regions
d.Worldwide Markets for AD diagnostics by leading countries
i.USA
ii.Canada
iii.Japan
iv.Germany
e.Developments and Research

IV.Markets for Prevention
a.Overview
i.Risk factors
ii.Protective factors
iii.Supplements
b.Worldwide markets for supplements in Alzheimer’s Disease prevention by segments
i.Vitamins
ii.Medication
iii.Herbal supplements
1.Gingko biloba
2.Curcumma
3.Omega-3 fatty acids
4.Tea
iv.Brain training
v.Others

V.Markets for Therapy
a.Overview of approved products/drugs
b.Worldwide Markets for Alzheimer’s Disease (AD) Medications by substance classes
c.Worldwide markets for Alzheimer Disease medications by products
d.Worldwide Markets for AD therapy by regions
e.Worldwide Markets for AD therapy by leading countries
f.Potential New Drugs/Drug Pipelines Phases I-III
i.Background
1.Phase I
2.Phase II
3.Phase III

VI.Markets for Patient care and management
a.Overview of management and care systems
b.Market for AD patient management worldwide
i.By severity of disease
1.Early
2.Moderate
3.Severe
ii.By institutions
1.Nursing homes
2.At home care/mobile
3.Specialized AD nursing homes
4.Others
iii.By regions
1.USA
2.West Europe
3.East Europe
4.Asia
5.Others
iv.By leading countries
v.Problems associated with patient care/management
vi.Future manegement and care situation

VII.Competition
a.Overview – Competition Structure
b.Leading Pharmaceutical manufacturers
c.Drug Research and Patents
d.Market Share Analysis
e.Leading companies in AD Business by segments

VIII.Research and Developments
a.Field of research
i.Therapy
ii.Diagnostics
iii.Prevention
b.New Technologies
i.Nanotechnology
ii.Others





Pricing of the Study


Part A and B (Total Study)4900 Euro

To order please contact us hkc22@bluewin.ch




Alzheimer disease ( AD ) is a special form of dementia that can start as early as 45 years of age, but mostly around age 65. Alzheimer is one of the 60 known different dementia diseases.
By 2040 it is expected that there are worldwide over 190 million people living with
the Alzheimer's disease, in the third stage. Twice as many people do not even know that they are already in a stage of Alzheimer's Disease.

Today it is already a big and fast growing business worldwide and it will have high growth rates to 2040 and a market of over 4560 billion US $. Alzheimer's disease is developing
an industry with many branches, services and products and jobs on different levels.

This study discusses the state of science, applications, companies, research, leading medical institutions, associations, business and industries worldwide and the development
to 2040, by years and total. The study took over one year to complete by interviews
and using scientific materials, publications and company information. Alzheimer's Disease
must not be fate. There are diagnostic methods and prevention, pharmaceuticals and
devices, training and education. There are promising scientific research and developments
in several countries worldwide. The key is the early diagnosis, but alternative methods like Traditional Chinese Medicine can and will also play an important role in an early stage, similar to vitamins and minerals and more.